rabbit jak2 antibody Search Results


94
Bioss jak2(tyr1007+tyr1008) antibody
Jak2(tyr1007+Tyr1008) Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/jak2(tyr1007+tyr1008) antibody/product/Bioss
Average 94 stars, based on 1 article reviews
jak2(tyr1007+tyr1008) antibody - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

99
Danaher Inc rabbit antibodies against rab 5
Rabbit Antibodies Against Rab 5, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit antibodies against rab 5/product/Danaher Inc
Average 99 stars, based on 1 article reviews
rabbit antibodies against rab 5 - by Bioz Stars, 2026-05
99/100 stars
  Buy from Supplier

85
Rockland Immunochemicals anti jak2
Anti Jak2, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti jak2/product/Rockland Immunochemicals
Average 85 stars, based on 1 article reviews
anti jak2 - by Bioz Stars, 2026-05
85/100 stars
  Buy from Supplier

90
GeneTex p-janus kinase 2 (jak2) antibody
P Janus Kinase 2 (Jak2) Antibody, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p-janus kinase 2 (jak2) antibody/product/GeneTex
Average 90 stars, based on 1 article reviews
p-janus kinase 2 (jak2) antibody - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

94
Bioss jak2 polyclonal antibody
Jak2 Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/jak2 polyclonal antibody/product/Bioss
Average 94 stars, based on 1 article reviews
jak2 polyclonal antibody - by Bioz Stars, 2026-05
94/100 stars
  Buy from Supplier

90
OriGene jak2 rabbit polyclonal antibody
Jak2 Rabbit Polyclonal Antibody, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/jak2 rabbit polyclonal antibody/product/OriGene
Average 90 stars, based on 1 article reviews
jak2 rabbit polyclonal antibody - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc anti rabbit phospho jak2 tyr1007 1008 antibody
FGL2 enhances OXPHOS via the <t>JAK2–STAT3</t> signaling pathway in ENCCs (A) Gene Set Enrichment Analysis (GSEA) of RNA-seq data from ENCCs treated with rFGL2 (2.5 μg/mL, 6 h) revealed the upregulation of the JAK-STAT signaling pathway. (B) Immunofluorescence staining showed the nuclear accumulation of phosphorylated STAT3 (p-STAT3) upon FGL2 stimulation, which was reduced by pretreatment with JAK2 inhibitor AG490 (50 μM) or STAT3 inhibitor Stattic (5 μM). Scale bar = 20 μm. n = 3 wells per group. (C) Western blot analysis of phosphorylated and total JAK2 and STAT3 in ENCCs treated with FGL2, AG490, or Stattic. Quantification confirmed the activation of JAK2–STAT3 by FGL2 and suppression by respective inhibitors. Data are presented as mean ± SEM, n = 3 wells per group. Western blot analysis of representative OXPHOS complex proteins (ATP5A1, UQCRC1, SDHB, MTCO2, NDUFB8) revealed increased expression after FGL2 treatment, attenuated by JAK2 or STAT3 inhibition. β-ACTIN was used as a loading control. n = 3 wells per group. (D) Seahorse XF Cell Mito Stress Test showed increased oxygen consumption rate (OCR) in ENCCs following FGL2 treatment, which was significantly reversed by the inhibition of JAK2 or STAT3. Basal respiration, maximal respiration, spare respiratory capacity, and proton leak were quantified, n = 3 wells per group. (E and F) Flow cytometry detection of intracellular ROS levels (DCFH-DA staining) indicated that FGL2-induced ROS accumulation was reduced upon treatment with AG490 or Stattic. Data are presented as mean ± SEM. Statistical analysis was performed using an unpaired two-tailed t-test. Significance reported as ∗ p < 0.05, ∗∗ p < 0.01. n = 3 wells per group.
Anti Rabbit Phospho Jak2 Tyr1007 1008 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti rabbit phospho jak2 tyr1007 1008 antibody/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
anti rabbit phospho jak2 tyr1007 1008 antibody - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc rabbit anti human jak2 antibody
FGL2 enhances OXPHOS via the <t>JAK2–STAT3</t> signaling pathway in ENCCs (A) Gene Set Enrichment Analysis (GSEA) of RNA-seq data from ENCCs treated with rFGL2 (2.5 μg/mL, 6 h) revealed the upregulation of the JAK-STAT signaling pathway. (B) Immunofluorescence staining showed the nuclear accumulation of phosphorylated STAT3 (p-STAT3) upon FGL2 stimulation, which was reduced by pretreatment with JAK2 inhibitor AG490 (50 μM) or STAT3 inhibitor Stattic (5 μM). Scale bar = 20 μm. n = 3 wells per group. (C) Western blot analysis of phosphorylated and total JAK2 and STAT3 in ENCCs treated with FGL2, AG490, or Stattic. Quantification confirmed the activation of JAK2–STAT3 by FGL2 and suppression by respective inhibitors. Data are presented as mean ± SEM, n = 3 wells per group. Western blot analysis of representative OXPHOS complex proteins (ATP5A1, UQCRC1, SDHB, MTCO2, NDUFB8) revealed increased expression after FGL2 treatment, attenuated by JAK2 or STAT3 inhibition. β-ACTIN was used as a loading control. n = 3 wells per group. (D) Seahorse XF Cell Mito Stress Test showed increased oxygen consumption rate (OCR) in ENCCs following FGL2 treatment, which was significantly reversed by the inhibition of JAK2 or STAT3. Basal respiration, maximal respiration, spare respiratory capacity, and proton leak were quantified, n = 3 wells per group. (E and F) Flow cytometry detection of intracellular ROS levels (DCFH-DA staining) indicated that FGL2-induced ROS accumulation was reduced upon treatment with AG490 or Stattic. Data are presented as mean ± SEM. Statistical analysis was performed using an unpaired two-tailed t-test. Significance reported as ∗ p < 0.05, ∗∗ p < 0.01. n = 3 wells per group.
Rabbit Anti Human Jak2 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti human jak2 antibody/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
rabbit anti human jak2 antibody - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Cell Signaling Technology Inc phospho jak2 rabbit antibody
FGL2 enhances OXPHOS via the <t>JAK2–STAT3</t> signaling pathway in ENCCs (A) Gene Set Enrichment Analysis (GSEA) of RNA-seq data from ENCCs treated with rFGL2 (2.5 μg/mL, 6 h) revealed the upregulation of the JAK-STAT signaling pathway. (B) Immunofluorescence staining showed the nuclear accumulation of phosphorylated STAT3 (p-STAT3) upon FGL2 stimulation, which was reduced by pretreatment with JAK2 inhibitor AG490 (50 μM) or STAT3 inhibitor Stattic (5 μM). Scale bar = 20 μm. n = 3 wells per group. (C) Western blot analysis of phosphorylated and total JAK2 and STAT3 in ENCCs treated with FGL2, AG490, or Stattic. Quantification confirmed the activation of JAK2–STAT3 by FGL2 and suppression by respective inhibitors. Data are presented as mean ± SEM, n = 3 wells per group. Western blot analysis of representative OXPHOS complex proteins (ATP5A1, UQCRC1, SDHB, MTCO2, NDUFB8) revealed increased expression after FGL2 treatment, attenuated by JAK2 or STAT3 inhibition. β-ACTIN was used as a loading control. n = 3 wells per group. (D) Seahorse XF Cell Mito Stress Test showed increased oxygen consumption rate (OCR) in ENCCs following FGL2 treatment, which was significantly reversed by the inhibition of JAK2 or STAT3. Basal respiration, maximal respiration, spare respiratory capacity, and proton leak were quantified, n = 3 wells per group. (E and F) Flow cytometry detection of intracellular ROS levels (DCFH-DA staining) indicated that FGL2-induced ROS accumulation was reduced upon treatment with AG490 or Stattic. Data are presented as mean ± SEM. Statistical analysis was performed using an unpaired two-tailed t-test. Significance reported as ∗ p < 0.05, ∗∗ p < 0.01. n = 3 wells per group.
Phospho Jak2 Rabbit Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phospho jak2 rabbit antibody/product/Cell Signaling Technology Inc
Average 86 stars, based on 1 article reviews
phospho jak2 rabbit antibody - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

N/A
JAK2 pTyr1007 rabbit polyclonal antibody Aff Purified
  Buy from Supplier

N/A
Rabbit anti-Human Phospho-JAK2 Polyclonal Antibody
  Buy from Supplier

Image Search Results


FGL2 enhances OXPHOS via the JAK2–STAT3 signaling pathway in ENCCs (A) Gene Set Enrichment Analysis (GSEA) of RNA-seq data from ENCCs treated with rFGL2 (2.5 μg/mL, 6 h) revealed the upregulation of the JAK-STAT signaling pathway. (B) Immunofluorescence staining showed the nuclear accumulation of phosphorylated STAT3 (p-STAT3) upon FGL2 stimulation, which was reduced by pretreatment with JAK2 inhibitor AG490 (50 μM) or STAT3 inhibitor Stattic (5 μM). Scale bar = 20 μm. n = 3 wells per group. (C) Western blot analysis of phosphorylated and total JAK2 and STAT3 in ENCCs treated with FGL2, AG490, or Stattic. Quantification confirmed the activation of JAK2–STAT3 by FGL2 and suppression by respective inhibitors. Data are presented as mean ± SEM, n = 3 wells per group. Western blot analysis of representative OXPHOS complex proteins (ATP5A1, UQCRC1, SDHB, MTCO2, NDUFB8) revealed increased expression after FGL2 treatment, attenuated by JAK2 or STAT3 inhibition. β-ACTIN was used as a loading control. n = 3 wells per group. (D) Seahorse XF Cell Mito Stress Test showed increased oxygen consumption rate (OCR) in ENCCs following FGL2 treatment, which was significantly reversed by the inhibition of JAK2 or STAT3. Basal respiration, maximal respiration, spare respiratory capacity, and proton leak were quantified, n = 3 wells per group. (E and F) Flow cytometry detection of intracellular ROS levels (DCFH-DA staining) indicated that FGL2-induced ROS accumulation was reduced upon treatment with AG490 or Stattic. Data are presented as mean ± SEM. Statistical analysis was performed using an unpaired two-tailed t-test. Significance reported as ∗ p < 0.05, ∗∗ p < 0.01. n = 3 wells per group.

Journal: iScience

Article Title: FGL2-induced metabolic dysregulation in enteric neural crest cells provides insight into Hirschsprung disease pathogenesis

doi: 10.1016/j.isci.2025.113423

Figure Lengend Snippet: FGL2 enhances OXPHOS via the JAK2–STAT3 signaling pathway in ENCCs (A) Gene Set Enrichment Analysis (GSEA) of RNA-seq data from ENCCs treated with rFGL2 (2.5 μg/mL, 6 h) revealed the upregulation of the JAK-STAT signaling pathway. (B) Immunofluorescence staining showed the nuclear accumulation of phosphorylated STAT3 (p-STAT3) upon FGL2 stimulation, which was reduced by pretreatment with JAK2 inhibitor AG490 (50 μM) or STAT3 inhibitor Stattic (5 μM). Scale bar = 20 μm. n = 3 wells per group. (C) Western blot analysis of phosphorylated and total JAK2 and STAT3 in ENCCs treated with FGL2, AG490, or Stattic. Quantification confirmed the activation of JAK2–STAT3 by FGL2 and suppression by respective inhibitors. Data are presented as mean ± SEM, n = 3 wells per group. Western blot analysis of representative OXPHOS complex proteins (ATP5A1, UQCRC1, SDHB, MTCO2, NDUFB8) revealed increased expression after FGL2 treatment, attenuated by JAK2 or STAT3 inhibition. β-ACTIN was used as a loading control. n = 3 wells per group. (D) Seahorse XF Cell Mito Stress Test showed increased oxygen consumption rate (OCR) in ENCCs following FGL2 treatment, which was significantly reversed by the inhibition of JAK2 or STAT3. Basal respiration, maximal respiration, spare respiratory capacity, and proton leak were quantified, n = 3 wells per group. (E and F) Flow cytometry detection of intracellular ROS levels (DCFH-DA staining) indicated that FGL2-induced ROS accumulation was reduced upon treatment with AG490 or Stattic. Data are presented as mean ± SEM. Statistical analysis was performed using an unpaired two-tailed t-test. Significance reported as ∗ p < 0.05, ∗∗ p < 0.01. n = 3 wells per group.

Article Snippet: Anti-rabbit Phospho-Jak2 (Tyr1007/1008) Antibody , Cell Signaling Technology , Cat# 3771; RRID: AB_330403.

Techniques: RNA Sequencing, Immunofluorescence, Staining, Western Blot, Activation Assay, Expressing, Inhibition, Control, Flow Cytometry, Two Tailed Test